GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response

Previous studies indicated that G-protein coupled receptor 174 (GPR174) is involved in the dysregulated immune response of sepsis, however, the clinical value and effects of GPR174 in septic patients are still unknown. This study is aimed to evaluate the potential value of GPR174 as a prognostic bio...

Full description

Bibliographic Details
Main Authors: Jianli Wang, Yanyan Hu, Zhongshu Kuang, Yao Chen, Lingyu Xing, Wei Wei, Mingming Xue, Sucheng Mu, Chaoyang Tong, Yilin Yang, Zhenju Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.789141/full
_version_ 1828136738067841024
author Jianli Wang
Yanyan Hu
Zhongshu Kuang
Yao Chen
Lingyu Xing
Wei Wei
Mingming Xue
Sucheng Mu
Chaoyang Tong
Yilin Yang
Zhenju Song
Zhenju Song
Zhenju Song
author_facet Jianli Wang
Yanyan Hu
Zhongshu Kuang
Yao Chen
Lingyu Xing
Wei Wei
Mingming Xue
Sucheng Mu
Chaoyang Tong
Yilin Yang
Zhenju Song
Zhenju Song
Zhenju Song
author_sort Jianli Wang
collection DOAJ
description Previous studies indicated that G-protein coupled receptor 174 (GPR174) is involved in the dysregulated immune response of sepsis, however, the clinical value and effects of GPR174 in septic patients are still unknown. This study is aimed to evaluate the potential value of GPR174 as a prognostic biomarker for sepsis and explore the pathological function of GPR174 in cecal ligation and puncture (CLP)-induced septic mice. In this prospective longitudinal study, the expressions of peripheral GPR174 mRNA were measured in 101 septic patients, 104 non-septic ICU controls, and 46 healthy volunteers at Day 1, 7 after ICU (Intensive Care Unit) admission, respectively. Then, the clinical values of GPR174 for the diagnosis, severity assessment, and prognosis of sepsis were analyzed. Moreover, the expressions of GPR174 mRNA in CLP-induced septic mice were detected, and Gpr174-knockout (KO) mice were used to explore its effects on inflammation. The results showed that the levels of GPR174 mRNA were significantly decreased in septic patients compared with non-septic ICU and healthy controls. In addition, the expressions of GPR174 mRNA were correlated with the lymphocyte (Lym) counts, C-reactive protein (CRP), and APACHE II and SOFA scores. The levels of GPR174 mRNA at Day 7 had a high AUC in predicting the death of sepsis (0.83). Further, we divided the septic patients into the higher and lower GPR174 mRNA expression groups by the ROC cut-off point, and the lower group was significantly associated with poor survival rate (P = 0.00139). Similarly, the expressions of peripheral Gpr174 mRNA in CLP-induced septic mice were also significantly decreased, and recovered after 72 h. Intriguingly, Gpr174-deficient could successfully improve the outcome with less multi-organ damage, which was mainly due to an increased level of IL-10, and decreased levels of IL-1β and TNF-α. Further, RNA-seq showed that Gpr174 deficiency significantly induced a phenotypic shift toward multiple immune response pathways in septic mice. In summary, our results indicated that the expressions of GPR174 mRNA were associated with the severity of sepsis, suggesting that GPR174 could be a potential prognosis biomarker for sepsis. In addition, GPR174 plays an important role in the development of sepsis by regulating the inflammatory response.
first_indexed 2024-04-11T18:09:01Z
format Article
id doaj.art-afab2051839547b9b8dadcacc39b2ea8
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-11T18:09:01Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-afab2051839547b9b8dadcacc39b2ea82022-12-22T04:10:13ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-01-011210.3389/fimmu.2021.789141789141GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory ResponseJianli Wang0Yanyan Hu1Zhongshu Kuang2Yao Chen3Lingyu Xing4Wei Wei5Mingming Xue6Sucheng Mu7Chaoyang Tong8Yilin Yang9Zhenju Song10Zhenju Song11Zhenju Song12Department of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Emergency Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaShanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, ChinaShanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, ChinaPrevious studies indicated that G-protein coupled receptor 174 (GPR174) is involved in the dysregulated immune response of sepsis, however, the clinical value and effects of GPR174 in septic patients are still unknown. This study is aimed to evaluate the potential value of GPR174 as a prognostic biomarker for sepsis and explore the pathological function of GPR174 in cecal ligation and puncture (CLP)-induced septic mice. In this prospective longitudinal study, the expressions of peripheral GPR174 mRNA were measured in 101 septic patients, 104 non-septic ICU controls, and 46 healthy volunteers at Day 1, 7 after ICU (Intensive Care Unit) admission, respectively. Then, the clinical values of GPR174 for the diagnosis, severity assessment, and prognosis of sepsis were analyzed. Moreover, the expressions of GPR174 mRNA in CLP-induced septic mice were detected, and Gpr174-knockout (KO) mice were used to explore its effects on inflammation. The results showed that the levels of GPR174 mRNA were significantly decreased in septic patients compared with non-septic ICU and healthy controls. In addition, the expressions of GPR174 mRNA were correlated with the lymphocyte (Lym) counts, C-reactive protein (CRP), and APACHE II and SOFA scores. The levels of GPR174 mRNA at Day 7 had a high AUC in predicting the death of sepsis (0.83). Further, we divided the septic patients into the higher and lower GPR174 mRNA expression groups by the ROC cut-off point, and the lower group was significantly associated with poor survival rate (P = 0.00139). Similarly, the expressions of peripheral Gpr174 mRNA in CLP-induced septic mice were also significantly decreased, and recovered after 72 h. Intriguingly, Gpr174-deficient could successfully improve the outcome with less multi-organ damage, which was mainly due to an increased level of IL-10, and decreased levels of IL-1β and TNF-α. Further, RNA-seq showed that Gpr174 deficiency significantly induced a phenotypic shift toward multiple immune response pathways in septic mice. In summary, our results indicated that the expressions of GPR174 mRNA were associated with the severity of sepsis, suggesting that GPR174 could be a potential prognosis biomarker for sepsis. In addition, GPR174 plays an important role in the development of sepsis by regulating the inflammatory response.https://www.frontiersin.org/articles/10.3389/fimmu.2021.789141/fullGPR174sepsisbiomarkerprognosisimmune response
spellingShingle Jianli Wang
Yanyan Hu
Zhongshu Kuang
Yao Chen
Lingyu Xing
Wei Wei
Mingming Xue
Sucheng Mu
Chaoyang Tong
Yilin Yang
Zhenju Song
Zhenju Song
Zhenju Song
GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response
Frontiers in Immunology
GPR174
sepsis
biomarker
prognosis
immune response
title GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response
title_full GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response
title_fullStr GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response
title_full_unstemmed GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response
title_short GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response
title_sort gpr174 mrna acts as a novel prognostic biomarker for patients with sepsis via regulating the inflammatory response
topic GPR174
sepsis
biomarker
prognosis
immune response
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.789141/full
work_keys_str_mv AT jianliwang gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT yanyanhu gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT zhongshukuang gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT yaochen gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT lingyuxing gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT weiwei gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT mingmingxue gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT suchengmu gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT chaoyangtong gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT yilinyang gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT zhenjusong gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT zhenjusong gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse
AT zhenjusong gpr174mrnaactsasanovelprognosticbiomarkerforpatientswithsepsisviaregulatingtheinflammatoryresponse